Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
International Journal for Parasitology|December 3, 2014
Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasisAnupam Yadav, Ajay Amit, Rajesh Chaudhary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2011
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, IndiaPrabhat K Sinha, Johan van Griensven, Krishna Pandey, et al.
Clinical Pharmacology and Therapeutics|November 25, 2025
Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal DosingWan-Yu Chu, Om Prakash Singh, Shyam Sundar, et al.
Parasites & Vectors|December 3, 2025
The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunitiesSauman Singh-Phulgenda, Prabin Dahal, Brittany J Maguire, et al.
Journal of Biomolecular Structure & Dynamics|January 5, 2016
Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopesAjay Amit, Manas R Dikhit, Vijay Mahantesh, et al.
Parasitology|November 16, 2017
Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-IIManish K Singh, Fauzia Jamal, Amit K Dubey, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2010
Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, IndiaPrabhat K Sinha, Paul Roddy, Pedro Pablo Palma, et al.
Plos Neglected Tropical Diseases|September 27, 2019
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, IndiaVishal Goyal, Sakib Burza, Krishna Pandey, et al.
Plos One|August 19, 2017
Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosisFauzia Jamal, Pushkar Shivam, Sarita Kumari, et al.
Scientific Reports|September 23, 2018
The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte responseManas Ranjan Dikhit, Sushmita Das, Vijaya Mahantesh, et al.
Pageof 18